↓ Skip to main content

Cochrane Database of Systematic Reviews

Levetiracetam for neuropathic pain in adults

Overview of attention for article published in Cochrane database of systematic reviews, July 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

blogs
2 blogs
twitter
17 tweeters
wikipedia
1 Wikipedia page

Readers on

mendeley
179 Mendeley
Title
Levetiracetam for neuropathic pain in adults
Published in
Cochrane database of systematic reviews, July 2014
DOI 10.1002/14651858.cd010943.pub2
Pubmed ID
Authors

Wiffen, Philip J, Derry, Sheena, Moore, R Andrew, Lunn, Michael PT, Lunn, Michael P T

Abstract

Antiepileptic drugs have been used in pain management since the 1960s; some have shown efficacy in treating different neuropathic pain conditions. The efficacy of levetiracetam for relief of neuropathic pain has not previously been reviewed.

Twitter Demographics

The data shown below were collected from the profiles of 17 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 179 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Spain 1 <1%
Brazil 1 <1%
Unknown 176 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 39 22%
Student > Bachelor 25 14%
Researcher 15 8%
Student > Ph. D. Student 15 8%
Student > Doctoral Student 10 6%
Other 28 16%
Unknown 47 26%
Readers by discipline Count As %
Medicine and Dentistry 65 36%
Nursing and Health Professions 23 13%
Neuroscience 10 6%
Pharmacology, Toxicology and Pharmaceutical Science 9 5%
Agricultural and Biological Sciences 5 3%
Other 15 8%
Unknown 52 29%

Attention Score in Context

This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 August 2020.
All research outputs
#1,287,870
of 22,758,248 outputs
Outputs from Cochrane database of systematic reviews
#2,965
of 12,314 outputs
Outputs of similar age
#13,724
of 225,737 outputs
Outputs of similar age from Cochrane database of systematic reviews
#53
of 228 outputs
Altmetric has tracked 22,758,248 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,314 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.4. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 225,737 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 228 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.